Singapore Mobile health (mHealth) is an area of electronic health (eHealth) that offers revolutionized healthcare services through uniquesmartphone based technologies that enable the remote monitoring of patients. Increasing adoption of smartphones, growing awareness of newer technologies and increasing consumer preferences towards healthy lifestyles are prime factors that supplement the adoption of Singapore mHealth devices. Moreover, the continued growth in coverage of mobile cellular networks and increasing count of lifestyle diseases such as diabetes, obesity, including others would further drive the growth of the Singapore mHealth market. However, lower accuracy, weak reimbursement coverage and low adoption of devices among aging population are factors that could hinder the Singapore market growth.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1173
In the Singapore mHealth services market, monitoring was the largest revenue generating segment, accounting for about half of the mHealth services market share in 2014. Key factors responsible for the growth of Singapore mHealth services market include increasing government initiatives, growing awareness among patient population among others.
In the Singapore mHealth market, China and Japan collectively accounted for 2/3rd of the market revenue in 2014 and would continue to consolidate their Singapore market position over the forecast period. Furthermore,launch of innovative products and services largely contributes to the market growth in these countries. Key players profiled in this report include - Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Masimo Corporation, Sanofi, Boston Scientific, AT&T Inc., and Johnson & Johnson.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/asia-pacific-mhealth-market
.png)
0 Comments